Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × Interventional × Tablets × Clear all

Phase

Status

Completed 44 Recruiting 21 Unknown 9 Active not recruiting 7 Withdrawn 5 Terminated 5 Not yet recruiting 5 Suspended 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Interventions

Educational Status 6 Interviews as Topic 5 Fluorodeoxyglucose F18 5 Cisplatin 5 Standard of Care 4 Dexamethasone 4 camrelizumab 3 Radiotherapy 3 Nivolumab 3 Methods 3 Lenalidomide 3 Fluorouracil 3 Early Intervention, Educational 3 Cyclophosphamide 3 Carboplatin 3 130-nm albumin-bound paclitaxel 3 venetoclax 2 sintilimab 2 lenvatinib 2 fludarabine 2 durvalumab 2 Weights and Measures 2 Transcutaneous Electric Nerve Stimulation 2 Temozolomide 2 Specimen Handling 2 S 1 (combination) 2 Practice Guidelines as Topic 2 Patient Navigation 2 Paclitaxel 2 Oxaliplatin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04527055 2024-06-24

Bsm10

National Cheng-Kung University Hospital

Phase 4 Enrolling by invitation

Dysbiosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡